All articles tagged with #miracle drug
Hennepin Healthcare has decided to stop covering a "miracle" weight loss drug that had helped its employees shed pounds. The decision comes after concerns were raised about the drug's safety and effectiveness, prompting the healthcare provider to reevaluate its coverage policies.
An Ohio grandmother, Joan Murtaugh, who participated in a clinical trial at the Cleveland Clinic for the new Alzheimer's drug Leqembi (lecanemab), has reported significant improvements in her memory and overall functionality. Developed by Biogen and Eisai, Leqembi is the first drug proven to delay the progression of Alzheimer's by targeting the underlying disease process. Another promising Alzheimer's medication, donanemab, is expected to be approved by the FDA this fall. These breakthrough drugs mark the beginning of a new era in Alzheimer's therapies, offering hope for patients and their families.